Cargando…
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
In the past decade, remarkable progress has been made in reprogramming terminally differentiated somatic cells and cancer cells into induced pluripotent cells and cancer cells with benign phenotypes. Recent studies have explored various approaches to induce reprogramming from one cell type to anothe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716904/ https://www.ncbi.nlm.nih.gov/pubmed/31464654 http://dx.doi.org/10.1186/s40880-019-0393-5 |